GLP1R and Cognitive impairment: It leads to a conclusion that GLP-1 agonists may be valuable additional therapeutic option for BED patients but should not be regarded as a sole remedy since it is indispensable to address the emotional causes of eating disorders as there is evidence that individuals suffering from BED have cognitive deficits relating to uncertainty, inhibition, consistency, and flexibility [94].